Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.23 is 93% above its 2-year average of 2.72, around the middle of its 2-year range (0.02–13.18).
As of the fiscal period ended Tuesday, June 30, 2026. 40.98% above its 12-month average of 3.71.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.23.
CURRENT RATIO
5.23
CURRENT RATIO AVG TTM
3.71
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+40.98%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+39.50%
vs the sector median at left
YD Bio Limited Ordinary Shares
Market Cap
$435.61M
Current Ratio
5.23
TTM Avg
3.71
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$438.07M
Current Ratio
6.72
TTM Avg
10.04
3Y Avg
13.74
5Y Avg
16.43
Market Cap
$439.55M
Current Ratio
13.99
TTM Avg
3.82
3Y Avg
4.25
5Y Avg
5.96
Market Cap
$442.34M
Current Ratio
12.39
TTM Avg
8.12
3Y Avg
11.14
5Y Avg
10.14
Market Cap
$426.51M
Current Ratio
3.48
TTM Avg
10.77
3Y Avg
42.35
5Y Avg
30.00
Market Cap
$445.71M
Current Ratio
7.35
TTM Avg
8.39
3Y Avg
5.06
5Y Avg
6.73
Market Cap
$422.86M
Current Ratio
22.29
TTM Avg
19.64
3Y Avg
11.19
5Y Avg
11.30
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| YD Bio Limited Ordinary Shares (YDES) | $435.61M | 5.23 | 3.71 | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $438.07M | 6.72 | 10.04 | 13.74 | 16.43 |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | 4.94 | 5.33 | 6.32 | 7.54 |
| Assembly Biosciences, Inc. (ASMB)vs › | $439.55M | 13.99 | 3.82 | 4.25 | 5.96 |
| Ovid Therapeutics Inc. (OVID)vs › | $442.34M | 12.39 | 8.12 | 11.14 | 10.14 |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | 3.48 | 10.77 | 42.35 | 30.00 |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | 7.35 | 8.39 | 5.06 | 6.73 |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | 3.60 | 3.12 | 4.79 | 5.52 |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | 22.29 | 19.64 | 11.19 | 11.30 |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | 2.21 | 2.33 | 2.18 | 2.30 |
Current Ratio
5.23
Quick Ratio
3.46
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.23 |
| 2025-12-31 | 5.88 |
| 2025-06-30 | 0.02 |
| 2025-03-31 | 0.02 |
| 2024-12-31 | 13.18 |
| 2024-09-30 | 0.02 |
| 2024-06-30 | 0.03 |
| 2024-03-31 | 0.03 |
| 2023-12-31 | 0.03 |
